1. Home
  2. UDR vs RDY Comparison

UDR vs RDY Comparison

Compare UDR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UDR
  • RDY
  • Stock Information
  • Founded
  • UDR 1972
  • RDY 1984
  • Country
  • UDR United States
  • RDY India
  • Employees
  • UDR N/A
  • RDY N/A
  • Industry
  • UDR Real Estate Investment Trusts
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • UDR Real Estate
  • RDY Health Care
  • Exchange
  • UDR Nasdaq
  • RDY Nasdaq
  • Market Cap
  • UDR 14.6B
  • RDY 11.9B
  • IPO Year
  • UDR N/A
  • RDY N/A
  • Fundamental
  • Price
  • UDR $43.66
  • RDY N/A
  • Analyst Decision
  • UDR Buy
  • RDY Buy
  • Analyst Count
  • UDR 18
  • RDY 1
  • Target Price
  • UDR $44.56
  • RDY $17.00
  • AVG Volume (30 Days)
  • UDR 1.8M
  • RDY 1.5M
  • Earning Date
  • UDR 02-04-2025
  • RDY 01-28-2025
  • Dividend Yield
  • UDR 3.92%
  • RDY 3.72%
  • EPS Growth
  • UDR N/A
  • RDY 4.63
  • EPS
  • UDR 0.37
  • RDY 0.76
  • Revenue
  • UDR $1,677,719,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • UDR N/A
  • RDY $13.39
  • Revenue Next Year
  • UDR $0.89
  • RDY $8.35
  • P/E Ratio
  • UDR $116.20
  • RDY $20.65
  • Revenue Growth
  • UDR 0.06
  • RDY 12.37
  • 52 Week Low
  • UDR $34.19
  • RDY $13.41
  • 52 Week High
  • UDR $47.55
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • UDR 44.48
  • RDY 69.12
  • Support Level
  • UDR $42.33
  • RDY $14.45
  • Resistance Level
  • UDR $43.84
  • RDY $15.55
  • Average True Range (ATR)
  • UDR 0.80
  • RDY 0.18
  • MACD
  • UDR -0.18
  • RDY 0.17
  • Stochastic Oscillator
  • UDR 42.38
  • RDY 95.96

About UDR UDR Inc.

UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized prior to January 1, 2021, and held as of December 31, 2022, and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: